PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 67 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,883 | +0.6% | 10,280 | 0.0% | 0.00% | – |
| Q4 2023 | $1,871 | -38.9% | 10,280 | 0.0% | 0.00% | – |
| Q3 2023 | $3,063 | +80.1% | 10,280 | 0.0% | 0.00% | – |
| Q2 2023 | $1,701 | -83.0% | 10,280 | 0.0% | 0.00% | – |
| Q1 2023 | $10,033 | -6.2% | 10,280 | 0.0% | 0.00% | – |
| Q4 2022 | $10,691 | -10.9% | 10,280 | 0.0% | 0.00% | – |
| Q3 2022 | $12,000 | -36.8% | 10,280 | 0.0% | 0.00% | – |
| Q2 2022 | $19,000 | -38.7% | 10,280 | 0.0% | 0.00% | – |
| Q1 2022 | $31,000 | -20.5% | 10,280 | 0.0% | 0.00% | – |
| Q4 2021 | $39,000 | -26.4% | 10,280 | 0.0% | 0.00% | – |
| Q3 2021 | $53,000 | +35.9% | 10,280 | 0.0% | 0.00% | – |
| Q2 2021 | $39,000 | +50.0% | 10,280 | 0.0% | 0.00% | – |
| Q1 2021 | $26,000 | 0.0% | 10,280 | 0.0% | 0.00% | – |
| Q4 2020 | $26,000 | +23.8% | 10,280 | 0.0% | 0.00% | – |
| Q3 2020 | $21,000 | -34.4% | 10,280 | 0.0% | 0.00% | – |
| Q2 2020 | $32,000 | +39.1% | 10,280 | 0.0% | 0.00% | – |
| Q1 2020 | $23,000 | -37.8% | 10,280 | 0.0% | 0.00% | – |
| Q4 2019 | $37,000 | +5.7% | 10,280 | 0.0% | 0.00% | – |
| Q3 2019 | $35,000 | -27.1% | 10,280 | 0.0% | 0.00% | – |
| Q2 2019 | $48,000 | +41.2% | 10,280 | 0.0% | 0.00% | – |
| Q1 2019 | $34,000 | +25.9% | 10,280 | 0.0% | 0.00% | – |
| Q4 2018 | $27,000 | -53.4% | 10,280 | 0.0% | 0.00% | – |
| Q3 2018 | $58,000 | +11.5% | 10,280 | 0.0% | 0.00% | – |
| Q2 2018 | $52,000 | -25.7% | 10,280 | 0.0% | 0.00% | – |
| Q1 2018 | $70,000 | -10.3% | 10,280 | 0.0% | 0.00% | – |
| Q4 2017 | $78,000 | +32.2% | 10,280 | 0.0% | 0.00% | – |
| Q3 2017 | $59,000 | – | 10,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,360,000 | $6,895,000 | 5.06% |
| Omega Fund Management, LLC | 778,230 | $3,946,000 | 2.91% |
| BVF INC/IL | 5,346,838 | $27,108,000 | 2.65% |
| Virtus ETF Advisers LLC | 152,550 | $773,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 842,632 | $4,272,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $10,583,000 | 0.40% |
| Schonfeld Strategic Advisors LLC | 828,600 | $4,201,000 | 0.23% |
| Orbimed Advisors | 3,140,000 | $15,920,000 | 0.19% |
| Lombard Odier Asset Management (USA) Corp | 563,878 | $2,859,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,521,000 | 0.16% |